37 filings
Page 2 of 2
8-K
6g81dd32otycim5pvbg8
16 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:07pm
8-K
vcvtz9q6 arvf3zrk
9 Nov 22
Absci Reports Third Quarter 2022 Financial Results
9:18am
8-K
uhfcji
2 Nov 22
Absci Welcomes Meta Senior Executive to Board of Directors
4:06pm
8-K
j3x0igj7r 00k
4 Oct 22
Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer
4:09pm
8-K
8gvd0
20 Sep 22
Departure of Directors or Certain Officers
5:14pm
8-K
u8wgszvsdy416 1j
11 Aug 22
Absci Reports Second Quarter 2022 Financial Results and Business Update
8:33am
8-K
6qpmh7
14 Jul 22
Departure of Directors or Certain Officers
5:13pm
8-K
w6cxepet4vu0q
10 Jun 22
Submission of Matters to a Vote of Security Holders
5:18pm
8-K
cnpn49l7c3ole
11 May 22
Absci Reports First Quarter 2022 Financial and Operating Results
8:15am
8-K
cbggtjlj
22 Mar 22
Absci Reports Full Year 2021 Financial and Operating Results
4:07pm
8-K
w95fe6v
21 Mar 22
Departure of Directors or Certain Officers
4:20pm
8-K
n1rsaie7u5fiench8msd
10 Jan 22
Departure of Directors or Certain Officers
8:58am
8-K
gym9lqnw562p823lsrf
7 Jan 22
Absci Announces Research Collaboration with Merck
8:53am
8-K
8ys2r
9 Nov 21
Absci Reports Third Quarter 2021 Financial and Operating Results
8:02am
8-K
2wt0 bkebf
7 Sep 21
Absci Reports Second Quarter 2021 Financial and Operating Results
8:40am
8-K
5o0dgpyc82gudu
24 Aug 21
Departure of Directors or Certain Officers
9:03am
8-K
59nk ipb5
26 Jul 21
Amendments to Articles of Incorporation or Bylaws
4:01pm